🕵️ Scribe Therapeutics, Inc. ($SCTX)
SEC insider & ownership activity, last 12 months · CIK 1853921 · every row links its SEC filing
Over the last 12 months insiders bought $71.3M with no open-market selling against it. Aghazadeh Behzad bought $36.3M in discretionary trades (Jul). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
6 buyers, $71.3M (9 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Aghazadeh Behzad | 3 | $36.3M | 0 | – | Jul 28, 2026 |
| Orbimed Advisors LLC | 1 | $15.0M | 0 | – | Jul 27, 2026 |
| Carl L. Gordon | 1 | $15.0M | 0 | – | Jul 27, 2026 |
| AH BIO Fund II, L.P. | 1 | $5.0M | 0 | – | Jul 27, 2026 |
| Lucas Svetlana | 1 | $45K | 0 | – | Jul 23, 2026 |
| Parrot David | 2 | $40K | 0 | – | Jul 23, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 7.2% | 13D | Jul 27, 2026 | filing ↗ | |
| Orbimed Capital GP VIII LLC | 7.2% | 13D | Jul 27, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Charter/bylaw changes (5.03) | Jul 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 27, 2026 | filing ↗ |